Detection of Complement Factor B Autoantibodies by ELISA.

Area of Science:

• Immunology
• Complement System Biology
• Autoimmunity

Background:

• Autoantibodies are linked to numerous diseases, often by triggering pathological complement activation.
• Autoantibodies targeting complement proteins are particularly implicated in kidney diseases.
• Antibodies binding to complement convertases can enhance their stability and resistance to regulation, promoting complement turnover.

Purpose of the Study:

• To describe a novel ELISA method for detecting autoantibodies against factor B.
• To investigate if these autoantibodies bind to and stabilize the alternative complement pathway C3 convertase enzyme, C3bBb.

Main Methods:

• Development and application of an enzyme-linked immunosorbent assay (ELISA).
• Detection of autoantibodies targeting factor B.
• Assessment of antibody binding to and stabilization of the C3bBb complex.

Main Results:

• The study successfully developed an ELISA method to detect factor B autoantibodies.
• These autoantibodies were found to bind to the C3 convertase enzyme C3bBb.
• The binding of autoantibodies contributed to the stabilization of the C3bBb complex.

Conclusions:

• Factor B autoantibodies can bind to and stabilize the alternative pathway's C3 convertase, C3bBb.
• This stabilization may contribute to abnormal complement activation.
• The developed ELISA is a valuable tool for identifying factor B autoantibodies in diseases like kidney disease.